Navigation Links
Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance
Date:4/18/2008

system of the European Union."

Dr. Galina V. Balabanova, M.D., Executive Director of the EATA, remarked, "Osteotech and Osteocentre Bulgaria have been excellent partners and supporters of tissue banking in Bulgaria. They have a rich tradition in technological advancement and quality. Osteotech is also a key financial supporter of the collaboration we have with the Scoliosis Research Society, which allows us to provide pediatric spinal deformity surgery for children without healthcare insurance coverage."

The EATA, a public non-profit foundation authorized under the Bulgarian Transplant Law of 2007 and organized under the Bulgarian Public Foundations Law of 2001, is responsible for funding healthcare projects in Bulgaria for the public benefit, tissue transplantation, international patient referral services and pediatric spinal deformity surgery for children without healthcare insurance coverage. The EATA also provides financial management and fundraising to hospitals and providers participating in the Bulgarian national donor recovery network.

Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global leader in providing OsteoBiologic solutions for regenerative medicine to support surgeons and their patients in the repair of the musculoskeletal system through the development of innovative therapy-driven products that alleviate pain, promote biologic healing and restore function. For further information regarding Osteotech, this press release or the conference call, please go to Osteotech's website at http://www.osteotech.com.

Certain statements made throughout this press release that are not historical facts contain forward-looking statements (as such are defined in the Private Securities Litigation Reform Act of 1995) regarding the Company's future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believe
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Osteotech Announces First Quarter Earnings Release and Conference Call Schedule
2. U.S. Patent Office Confirms Validity of Osteotechs U.S. Patent No. 5,676,146
3. Osteotech to Present at the Sidoti Conference in New York
4. Osteotech Receives FDA Clearance for Plexur M(TM) Biocomposite
5. Osteotech to Present at the Canaccord Adams Small-Cap Orthopedics Conference in San Francisco
6. Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
7. Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule
8. Osteotech to Present at Sidoti Conference in San Francisco
9. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
10. Biomaxx Systems Inc. Renews Membership With Bioenergy Australia
11. Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... of Compensatory Award Will Now Proceed -, MADISON, N.J., ... its motion for judgment as a matter of law on ... Scroggin v.,Wyeth, in the U.S. District Court, Eastern District of ... punitive damages award of,$19,360,000 rendered by the Little Rock jury ...
... USA Study to Evaluate Treatment of Coronary Artery Disease ... Patients in Real-World Setting, ... of the XIENCE V(TM) USA post-approval study, with six,hospital centers already ... Drug Administration approved the XIENCE V(TM),Everolimus Eluting Coronary Stent System. The ...
... 10 most promising drugs ... TSX Exchange Symbol: ... the "Company") (TSX:RVX) novel lead ApoA-I drug,candidate, RVX-208 has been ... (CVD) drugs available for strategic partnering by an,independent committee assembled ...
Cached Biology Technology:Wyeth's Motion to Overturn Punitive Damages Award Granted by Arkansas Court 2Wyeth's Motion to Overturn Punitive Damages Award Granted by Arkansas Court 3Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent 2Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent 3Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent 4Industry Leaders Select Resverlogix's RVX-208 2Industry Leaders Select Resverlogix's RVX-208 3
(Date:12/3/2014)... , Dec. 2, 2014   Marvin ... deployed, innovative test solutions for military, aerospace, and ... version of its successful TS-900 PXI semiconductor ... and features of high-end systems to customers at ... value compared to traditional ATE. ...
(Date:11/21/2014)... , Nov. 20, 2014 C-Labs LLC, ... the Internet of Things (IoT), today announced the appointment ... chief operating officer. Previously a strategic advisor to the ... and operations. Mr. Traynor is based out of the ... He reports to Chris Muench , Chief Executive ...
(Date:11/18/2014)... , Nov. 18, 2014   EyeLock ... authentication solutions, and MorphoTrust USA (Safran), ... services, today announced a strategic partnership to offer ... motor vehicle administration (MVA), airport screening and financial ... identity-related solutions, MorphoTrust serves consumers through a nationwide ...
Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... bird flu virus H5N1 emerged in late 2005 and replaced ... southern China, despite an ongoing program to vaccinate poultry, according ... with scientists at St. Jude Children's Research Hospital. , The ... the increased occurrence of H5N1 poultry infections since October 2005, ...
... first large-scale analysis of proteins in the brains of ... and mechanisms that may one day lead to new ... in the current issue of Molecular Psychiatry, released on-line ... and point to profound changes in brain function related ...
... immune response to the 1918 influenza virus provides new ... in an article appearing online today in the journal ... 1918 virus triggers a hyperactive immune response that may ... their results suggest that it is the combination of ...
Cached Biology News:Control measures fail to stop spread of new H5N1 virus 2High-tech research shows cocaine changes proteins and brain function 2Mouse study reveals new clues about virulence of 1918 influenza virus 2Mouse study reveals new clues about virulence of 1918 influenza virus 3
... EA. Ultrospec 6300 pro UV/Visible ... the Pharmacopoeia in terms of instrument specification ... being able to be used for rapid, ... excellent scanning capability., *Press to read high ...
... Cy3 Ab Labeling Kit, 1 kit. ... with CyDye fluorescent dyes. Conjugations are ... complete within 1 h. Dyes are ... to ensure consistent labelings. Category: Blotting ...
nucleophosmin (nucleolar phosphoprotein B23, numatrin), mRNA...
One-step, microplate or cuvet, colorimetric, detection range 0.78 ug/dL to 65 ug/dL Zn in serum, plasma, urine, saliva etc. Procedure: 10 min....
Biology Products: